{
  "thread": {
    "uuid": "818e1bdec405091ce5403c0825decac417bf02e4",
    "url": "https://www.themountainpress.com/lifestyles/health/fda-approves-qfitlia-to-cut-bleeding-episodes-in-patients-with-hemophilia/image_44c07bef-379e-533a-ada5-70477fdb290d.html",
    "site_full": "www.themountainpress.com",
    "site": "themountainpress.com",
    "site_section": "http://www.themountainpress.com/search/?f=rss&amp;t=article&amp;c=morgan&amp;l=50&amp;s=start_time&amp;sd=desc",
    "site_categories": [
      "media"
    ],
    "section_title": "www.themountainpress.com - RSS Results",
    "site_title": "themountainpress.com | Sevierville's Trusted Information Leader since 1879",
    "title": "FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia",
    "title_full": "FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia",
    "published": "2025-04-03T01:07:00.000+03:00",
    "replies_count": 0,
    "participants_count": 0,
    "site_type": "news",
    "country": "US",
    "main_image": "https://bloximages.newyork1.vip.townnews.com/themountainpress.com/content/tncms/assets/v3/editorial/4/4c/44c07bef-379e-533a-ada5-70477fdb290d/67edb6ef5f0eb.image.jpg?crop=1200%2C630%2C0%2C85",
    "performance_score": 0,
    "domain_rank": 146058,
    "domain_rank_updated": "2025-04-01T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "818e1bdec405091ce5403c0825decac417bf02e4",
  "url": "https://www.themountainpress.com/lifestyles/health/fda-approves-qfitlia-to-cut-bleeding-episodes-in-patients-with-hemophilia/image_44c07bef-379e-533a-ada5-70477fdb290d.html",
  "ord_in_thread": 0,
  "author": null,
  "published": "2025-04-03T01:07:00.000+03:00",
  "title": "FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia",
  "text": "FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia\n- Updated\nAs featured on\nWEDNESDAY, April 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "positive",
  "categories": [
    "Health",
    "Science and Technology"
  ],
  "topics": [
    "Health->health care approach",
    "Health->health treatment and procedure",
    "Health->medical specialisation",
    "Science and Technology->medical research",
    "Science and Technology->biomedical science"
  ],
  "ai_allow": false,
  "has_canonical": false,
  "breaking": false,
  "webz_reporter": false,
  "external_links": [],
  "entities": {
    "persons": [
      {
        "name": "Qfitlia",
        "sentiment": "neutral"
      }
    ],
    "locations": [],
    "organizations": [
      {
        "name": "FDA",
        "sentiment": "neutral",
        "tickers": []
      },
      {
        "name": "HealthDay News",
        "sentiment": "neutral",
        "tickers": []
      },
      {
        "name": "The U.S. Food and Drug Administration",
        "sentiment": "neutral",
        "tickers": []
      },
      {
        "name": "IX",
        "sentiment": "neutral",
        "tickers": []
      }
    ]
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "bias": null
  },
  "rating": null,
  "crawled": "2025-04-03T01:23:42.408+03:00",
  "updated": "2025-04-03T01:23:42.408+03:00"
}